Elizabeth Wamoni
Overview
Explore the profile of Elizabeth Wamoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Irungu E, Musau M, Nyerere B, Dollah A, Kwach B, Owidi E, et al.
PLOS Glob Public Health
. 2023 Mar;
2(3):e0000092.
PMID: 36962311
Delivery of oral PrEP, a potent HIV prevention intervention, has begun within public health systems in many countries in Africa. Training as many health providers as possible expeditiously is necessary...
2.
Irungu E, Mugwanya K, Mugo N, Bukusi E, Donnell D, Odoyo J, et al.
Lancet Glob Health
. 2021 Nov;
9(12):e1730-e1739.
PMID: 34798031
Background: Successful and sustainable models for HIV pre-exposure prophylaxis (PrEP) delivery in public health systems in Africa are needed. We aimed to evaluate the implementation of PrEP delivery integrated in...
3.
Irungu E, Odoyo J, Wamoni E, Bukusi E, Mugo N, Ngure K, et al.
J Int AIDS Soc
. 2021 Sep;
24(9):e25799.
PMID: 34496148
Introduction: In Africa, oral pre-exposure prophylaxis (PrEP) is largely provided via over-burdened public HIV care clinics. Successfully incorporating PrEP services into these clinics may require adaptations to practices outlined in...
4.
Peebles K, Mugwanya K, Irungu E, Odoyo J, Wamoni E, Morton J, et al.
BMC Health Serv Res
. 2021 Aug;
21(1):823.
PMID: 34399736
Background: In 2017, the Kenyan Ministry of Health integrated provision of pre-exposure prophylaxis (PrEP) into public HIV-1 care clinics as a key component of the national HIV-1 prevention strategy. Estimates...
5.
Ongolly F, Dolla A, Ngure K, Irungu E, Odoyo J, Wamoni E, et al.
J Acquir Immune Defic Syndr
. 2021 Jan;
87(1):e150-e158.
PMID: 33492024
Background: Preexposure prophylaxis (PrEP) discontinuation rates in clinical trials and demonstration projects have been well characterized; however, little is known about discontinuation in routine public health settings in sub-Saharan Africa....
6.
Irungu E, Ngure K, Mugwanya K, Awuor M, Dollah A, Ongolly F, et al.
AIDS Care
. 2020 Mar;
33(1):92-100.
PMID: 32207327
Communication around condom use in the context of PrEP services presents a potential conundrum for patients and providers. Within the Partners Scale-Up Project, which supports integration of PrEP delivery in...
7.
Ngure K, Ongolly F, Dolla A, Awour M, Mugwanya K, Irungu E, et al.
J Int AIDS Soc
. 2020 Mar;
23(3):e25466.
PMID: 32144888
Introduction: Sustained HIV viral suppression resulting from antiretroviral therapy (ART) eliminates the risk of HIV transmission, a concept popularly framed as Undetectable = Untransmittable (U = U). We explored knowledge...
8.
Irungu E, Ngure K, Mugwanya K, Mugo N, Bukusi E, Wamoni E, et al.
Glob Public Health
. 2019 Mar;
14(10):1524-1534.
PMID: 30871413
To catalyse national scale up of PrEP for HIV serodiscordant couples in public health facilities in Kenya, the Partners Scale-Up Project, using a two-day case-based interactive curriculum, trained health care...
9.
Mugwanya K, Irungu E, Bukusi E, Mugo N, Odoyo J, Wamoni E, et al.
Implement Sci
. 2018 Sep;
13(1):118.
PMID: 30180860
Background: Antiretroviral therapy (ART) for HIV-infected persons and pre-exposure prophylaxis (PrEP) for uninfected persons are extraordinarily effective strategies for HIV prevention. In Africa, the region which shoulders the highest HIV...